Billings Clinic
Especially For:

Clinical Trials

Title   Bladder Cancer (RTOG 0524): Non-Cystectomy Candidates w Muscle Invasive Bladder Cancer
Description   A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab with Daily Irradiation or Paclitaxel Alone with Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates with Muscle Invasive Bladder Cancer
IRB Number   RTOG R0524
Category   Genitourinary
Inclusion/Notes   Stage T2-T4a, Nx, N0 or N1; and M0or T1 with TCC grade 3/3 with histologic evidence of muscularis propria invasion and felt to require definitive local control. Cannot have prior chemo or radiation.
Status   Active
Start Date   09/12/2008
Principal Investigator (PI)   John Schallenkamp, MD
Physician Profile   Radiation Oncologist
Contact Name   Susan Dillon, RN
Contact Email   sdillon1@billingsclinic.org
Phone   (406) 435-7443
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.